The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Coumarins: Old Compounds with Novel Promising Therapeutic Perspectives
Open accessAbstract
Natural as well as synthetic coumarins have recently drawn much attention due to its broad pharmacological activities. Many coumarins and their derivatives exert anti-coagulant, anti-tumor, anti-viral, anti-inflammatory and anti-oxidant effects, as well as anti-microbial and enzyme inhibition properties. The recognition of key structural features within coumarin family is crucial for the design and development of new analogues with improved activity and for the characterization of their mechanism of action and potential side effects. The different substituents in the coumarin nucleus strongly influence the biological activity of the resulting derivatives. Although some coumarins have been already characterized to evoke a particular biological activity, the challenge would be the design and synthesis of new derivatives with high specific activity for other pharmacological targets and define their mechanism of action to achieve new therapeutic drugs. The present review highlights the current progress in the development of coumarin scaffolds for drug discovery as novel anti-cancer agents. The major challenges about coumarins include the translation of current knowledge into new potential lead compounds and the repositioning of known compounds for the treatment of cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Petersen, P., Godtfredsen, J., Boysen, G., Andersen, E., & Andersen, B. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91200-2 · Cited by 1,820
Natural and Synthetic Coumarin Derivatives with Anti-Inflammatory / Antioxidant Activities
Fylaktakidou, K., Hadjipavlou-Litina, D., Litinas, K., & Nicolaides, D. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043382710 · Cited by 970
Coumarins : biology, applications, and mode of action
O’Kennedy, R. J., & THORNES, R. D. (1997) · Medical Entomology and Zoology · Cited by 959
Hoult, J. R. S., & Payá, M. (1996) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(95)02112-4 · Cited by 951
Laughton, M. J., Evans, P. J., Moroney, M. A., Hoult, J. R. S., & Halliwell, B. (1991) · Biochemical Pharmacology · doi:10.1016/0006-2952(91)90501-u · Cited by 598
The Pharmacology, Metabolism, Analysis, and Applications of Coumarin and Coumarin-Related Compounds
Egan, D., O'kennedy, R., Moran, E., Cox, D., Prosser, E., & Thornes, R. D. (1990) · Drug Metabolism Reviews · doi:10.3109/03602539008991449 · Cited by 558
A Review of Coumarin Derivatives in Pharmacotherapy of Breast Cancer
Musa, M., Cooperwood, J., & Khan, M. O. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708786242877 · Cited by 538
Levine, M. N., Hirsh, J., Gent, M., Turpie, A. G., Weitz, J., Ginsberg, J., Geerts, W., LeClerc, J., Neemeh, J., Powers, P., et al. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649783 · Cited by 353
Differentiation therapy of leukemia: 3 decades of development.
Nowak, D., Stewart, D., & Koeffler, H. P. (2009) · Blood · doi:10.1182/blood-2009-01-198911 · Cited by 348
Lewis, R. J., Singh, O. M., Smith, C. V., Skarzynski, T., Maxwell, A., Wonacott, A. J., & Wigley, D. B. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00483.x · Cited by 335
Elbling, L., Weiss, R.-M., Teufelhofer, O., Uhl, M., Knasmueller, S., Schulte-Hermann, R., Berger, W., & Micksche, M. (2005) · The FASEB Journal · doi:10.1096/fj.04-2915fje · Cited by 313
Novobiocin and Additional Inhibitors of the Hsp90 C-Terminal Nucleotide- binding Pocket
Donnelly, A., & Blagg, B. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708786242895 · Cited by 313
Differentiation therapy of human cancer: basic science and clinical applications
Leszczyniecka, M., Roberts, T., Dent, P., Grant, S., & Fisher, P. B. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00132-2 · Cited by 292
Antioxidant and prooxidant action of eugenol-related compounds and their cytotoxicity
Fujisawa, S., Atsumi, T., Kadoma, Y., & Sakagami, H. (2002) · Toxicology · doi:10.1016/s0300-483x(02)00194-4 · Cited by 284
Anti-oxidant, pro-oxidant properties of tannic acid and its binding to DNA
Khan, N. S., Ahmad, A., & Hadi, S. M. (2000) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(00)00143-5 · Cited by 271
The interaction between coumarin drugs and DNA gyrase
Maxwell, A. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb01728.x · Cited by 264
Yoo, C.-B., Han, K.-T., Cho, K.-S., Ha, J., Park, H.-J., Nam, J.-H., Kil, U.-H., & Lee, K.-T. (2005) · Cancer Letters · doi:10.1016/j.canlet.2004.11.018 · Cited by 262
Novobiocin: Redesigning a DNA Gyrase Inhibitor for Selective Inhibition of Hsp90
Burlison, J. A., Neckers, L., Smith, A. B., Maxwell, A., & Blagg, B. S. J. (2006) · Journal of the American Chemical Society · doi:10.1021/ja065793p · Cited by 242
Stanway, S. J., Purohit, A., Woo, L. W. L., Sufi, S., Vigushin, D., Ward, R., Wilson, R. H., Stanczyk, F. Z., Dobbs, N., Kulinskaya, E., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1996 · Cited by 238
Buey, R. M., Barasoain, I., Jackson, E., Meyer, A., Giannakakou, P., Paterson, I., Mooberry, S., Andreu, J. M., & Díaz, J. F. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2005.09.010 · Cited by 231
Reversal of multidrug resistance in cancer cells by pyranocoumarins isolated from Radix Peucedani
Wu, J. Y.-C., Fong, W.-F., Zhang, J.-X., Leung, C.-H., Kwong, H.-L., Yang, M.-S., Li, D., & Cheung, H.-Y. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01946-0 · Cited by 221
Antibiotics and prevention of microbial colonization of catheters
Raad, I., Darouiche, R., Hachem, R., Sacilowski, M., & Bodey, G. P. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2397 · Cited by 211
Malhotra, S. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.113185 · Cited by 207
Inhibitory effect of esculetin on 5-lipoxygenase and leukotriene biosynthesis
Tomohiro, N., Yasuko, K., & Sei-Itsu, M. (1983) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(83)90106-6 · Cited by 198
Tinhofer, I., Bernhard, D., Senfter, M., Anether, G., Loeffler, M., Kroemer, G., Kofler, R., Csordas, A., & Greil, R. (2001) · The FASEB Journal · doi:10.1096/fj.00-0675fje · Cited by 183
The Redox Regulation of Thiol Dependent Signaling Pathways in Cancer
Giles, G. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206779010549 · Cited by 182
Structural insights into hydroxycoumarin-induced apoptosis in U-937 cells
Riveiro, M. E., Moglioni, A., Vazquez, R., Gomez, N., Facorro, G., Piehl, L., de Celis, E. R., Shayo, C., & Davio, C. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.11.038 · Cited by 173
Self-citationHsp90 Inhibitors Identified from a Library of Novobiocin Analogues
Yu, X. M., Shen, G., Neckers, L., Blake, H., Holzbeierlein, J., Cronk, B., & Blagg, B. S. J. (2005) · Journal of the American Chemical Society · doi:10.1021/ja0535864 · Cited by 172
Donnelly, A. C., Mays, J. R., Burlison, J. A., Nelson, J. T., Vielhauer, G. A., Holzbeierlein, J. M., & Blagg, B. S. J. (2008) · The Journal of Organic Chemistry · doi:10.1021/jo801312r · Cited by 156
VKORC1: molecular target of coumarins
Oldenburg, J., Watzka, M., Rost, S., & Müller, C. R. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02549.x · Cited by 150
Walsh, T. J., Standiford, H. C., Reboli, A. C., John, J. F., Mulligan, M. E., Ribner, B. S., Montgomerie, J. Z., Goetz, M. B., Mayhall, C. G., & Rimland, D. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.6.1334 · Cited by 145
Bras, G. L., Radanyi, C., Peyrat, J., Brion, J., Alami, M., Marsaud, V., Stella, B., & Renoir, J. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0707774 · Cited by 145
Burlison, J. A., Avila, C., Vielhauer, G. A., Lubbers, D. J., Holzbeierlein, J. M., & Blagg, B. S. J. (2008) · The Journal of Organic Chemistry · doi:10.1021/jo702191a · Cited by 138
Steroidal and Nonsteroidal Sulfamates as Potent Inhibitors of Steroid Sulfatase
Woo, L. W. L., Howarth, N. M., Purohit, A., Hejaz, H. A., Reed, M. J., & Potter, B. V. L. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970527v · Cited by 132
P-Glycoprotein - Implications of Metabolism of Neoplastic Cells and Cancer Therapy
Breier, A., Barančík, M., Sulová, Z., & Uhrík, B. (2005) · Current Cancer Drug Targets · doi:10.2174/1568009054863636 · Cited by 131
Verkman, A. S. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00397.2003 · Cited by 126
Dicoumarol: a unique microtubule stabilizing natural product that is synergistic with Taxol.
Madari, H. S., Panda, D., Wilson, L., & Jacobs, R. S. (2003) · PubMed · Cited by 124
The Rarity of Liver Toxicity in Patients Treated with Coumarin (1, 2-Benzopyrone)
Cox, D. M., O’Kennedy, R. J., & THORNES, R. D. (1989) · Human Toxicology · doi:10.1177/096032718900800612 · Cited by 113
Pharmacogenomics of 4-Hydroxycoumarin Anticoagulants
Au, N. T., & Rettie, A. E. (2008) · Drug Metabolism Reviews · doi:10.1080/03602530801952187 · Cited by 110
Induction of apoptosis by esculetin in human leukemia cells
Chu, C.-Y., Tsai, Y.-Y., Wang, C., Lin, W., & Tseng, T. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00859-7 · Cited by 109
Steroid Sulfatase: A New Target for the Endocrine Therapy of Breast Cancer
Stanway, S. J., Delavault, P., Purohit, A., Woo, L. W. L., Thurieau, C., Potter, B. V. L., & Reed, M. J. (2007) · The Oncologist · doi:10.1634/theoncologist.12-4-370 · Cited by 108
Marshall, M. E., Mendelsohn, L., Butler, K. M., Riley, L., Cantrell, J., Wiseman, C. L., Taylor, R. W., & Macdonald, J. S. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.6.862 · Cited by 108
Inhibition of P-Glycoprotein Transport Function by Grapefruit Juice Psoralen
Wang, E., Casciano, C. N., Clement, R. P., & Johnson, W. W. (2001) · Pharmaceutical Research · doi:10.1023/a:1011089924099 · Cited by 106
The prince and the pauper. A tale of anticancer targeted agents
Dueñas‐González, A., García‐López, P., Herrera, L. A., Medina‐Franco, J. L., González‐Fierro, A., & Candelaria, M. (2008) · Molecular Cancer · doi:10.1186/1476-4598-7-82 · Cited by 103
Phase II evaluation of coumarin (1,2‐benzopyrone) in metastatic prostatic carcinoma
Mohler, J. L., Gomella, L. G., Crawford, E. D., Glodé, L. M., Zippe, C. D., Fair, W. R., & Marshall, M. E. (1992) · The Prostate · doi:10.1002/pros.2990200208 · Cited by 97
Moridani, M. Y., Galati, G., & O'Brien, P. J. (2002) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00005-4 · Cited by 86
Goel, A., Prasad, A. K., Parmar, V. S., Ghosh, B., & Saini, N. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.04.052 · Cited by 84
Biological Activities of Novel Gyrase Inhibitors of the Aminocoumarin Class
Anderle, C., Stieger, M., Burrell, M. R., Reinelt, S., Maxwell, A., Page, M. G. P., & Heide, L. E. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01235-07 · Cited by 76
Identification of coumarin derivatives as a novel class of allosteric MEK1 inhibitors
Han, S., Zhou, V. W., Pan, S., Liu, Y., Hornsby, M. J., McMullan, D., Klock, H. E., Haugen, J., Lesley, S. A., Gray, N. S., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.08.097 · Cited by 73
Steroid sulphatase inhibitors for breast cancer therapy
Purohit, A., Woo, L. W. L., Chander, S. K., Newman, S. T., Ireson, C. R., Ho, Y., Grasso, A., Leese, M. P., Potter, B. V. L., & Reed, M. J. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00353-4 · Cited by 67
Hail, N., & Lotan, R. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700527 · Cited by 67
Hofmanová, J., Kozubík, A., Dušek, L., & Pacherník, J. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00264-7 · Cited by 64
Enhancement of esculetin on Taxol-induced apoptosis in human hepatoma HepG2 cells
Kuo, H., Lee, H.-J., Hu, C., Shun, H.-I., & Tseng, T. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2005.06.020 · Cited by 64
The Role of PUVA in the Treatment of Psoriasis
Gasparro, F. P. (2000) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200001060-00002 · Cited by 62
RAAD, I. I., Hachem, R. Y., Abi-Said, D., Rolston, K. V. I., Whimbey, E. E., Buzaid, A. C., & Legha, S. S. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980115)82:2<412::aid-cncr22>3.0.co;2-0 · Cited by 62
Warfarin inhibits metastasis of Mtln3 rat mammary carcinoma without affecting primary tumour growth
McCulloch, P. G., & George, W. (1989) · British Journal of Cancer · doi:10.1038/bjc.1989.37 · Cited by 56
Laurin, P., Ferroud, D., Schio, L., Klich, M., Dupuis‐Hamelin, C., Mauvais, P., Lassaigne, P., Bonnefoy, A., & Musicki, B. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00492-8 · Cited by 55
Apoptosis in cancer and atherosclerosis: polyphenol activities.
Giovannini, C., Scazzocchio, B., Varı́, R., Santangelo, C., D’Archivio, M., & Masella, R. (2007) · PubMed · Cited by 53
Prevention of early recurrence of high risk malignant melanoma by coumarin. Irish Melanoma Group.
Thornes, D., Daly, L., Lynch, G., Browne, H. Y., Tanner, A., Keane, F., O’Loughlin, S., Corrigan, T. P., Daly, P., & Edwards, G. (1989) · PubMed · Cited by 51
Non-steroidal and steroidal sulfamates: new drugs for cancer therapy
Purohit, A., Woo, L. W. L., Barrow, D., Hejaz, H. A., Nicholson, R. I., Potter, B. V. L., & Reed, M. J. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(00)00428-7 · Cited by 49
Shen, X., Chen, G., Zhu, G., & Fong, W. F. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.06.066 · Cited by 48
Esculetin induces mitochondria-mediated apoptosis in 3T3-L1 adipocytes
Yang, J., Della‐Fera, M. A., & Baile, C. A. (2006) · APOPTOSIS · doi:10.1007/s10495-006-7691-5 · Cited by 45
Kim, H.-R. (1994) · Oncology Reports · doi:10.3892/or_00000018 · Cited by 44
Comprehensive organic chemistry The synthesis and reactions of organic compounds
(1979) · Comparative Biochemistry and Physiology Part B Comparative Biochemistry · doi:10.1016/0305-0491(79)90219-0 · Cited by 40
The Development of Steroid Sulfatase Inhibitors for Hormone‐Dependent Cancer Therapy
Day, J. M., Purohit, A., Tutill, H. J., Foster, P., Woo, L. W. L., Potter, B. V. L., & Reed, M. J. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2008.03677.x · Cited by 38
Antitumour activity of coumarin in prostate and mammary cancer models
Angerer, E. V., Kager, M., & Maucher, A. (1994) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01377116 · Cited by 35
Tosylcyclonovobiocic acids promote cleavage of the hsp90-associated cochaperone p23
Radanyi, C., Bras, G. L., Bouclier, C., Messaoudi, S., Peyrat, J., Brion, J., Alami, M., & Renoir, J. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.12.102 · Cited by 31
Suicidal oxidative stress induced by certain antioxidants.
Koshy, L., Dwarakanath, B. S. R., Raj, H. G., Chandra, R., & Mathew, T. L. (2003) · PubMed · Cited by 31
Clinical trials with anticoagulant and antiplatelet therapies
Zacharski, L. R., Meehan, K. R., Martín‐Algarra, S., & Calvo, F. Á. (1992) · Cancer and Metastasis Reviews · doi:10.1007/bf01307191 · Cited by 28
A Coumarin from Mallotus resinosus that Mediates DNA Cleavage
Ma, J., Jones, S. H., & Hecht, S. M. (2004) · Journal of Natural Products · doi:10.1021/np040129c · Cited by 27
Sirangelo, I., Iannuzzi, C., Vilasi, S., Irace, G., Giuberti, G., Misso, G., D’Alessandro, A., Abbruzzese, A., & Caraglia, M. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21871 · Cited by 22
Coumarin modulates the cell-cycle progression of an MTV-EJras cell line
Kahn, J. S., Preis, P., Waldman, F. M., & Tseng, A. (1994) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01377118 · Cited by 10
Photosensitizing Compounds in the Treatment of Psoriasis
Hönigsmann, H., Tanew, A., Brücke, J., & Ortel, B. (2007) · Novartis Foundation symposium · doi:10.1002/9780470513842.ch11 · Cited by 10
Cited by
Bright Building Blocks for Chemical Biology
Lavis, L. D., & Raines, R. T. (2014) · ACS Chemical Biology · doi:10.1021/cb500078u · Cited by 536
Current Developments of Coumarin Compounds in Medicinal Chemistry
Peng, X.-M., L.V. Damu, G., & He Zhou, C. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319210013 · Cited by 504
Coumarin heterocyclic derivatives: chemical synthesis and biological activity
Medina, F. G., Marrero, J. G., Macías-Alonso, M., González, M. C., Córdova-Guerrero, I., Teissier García, A. G., & Osegueda-Robles, S. (2015) · Natural Product Reports · doi:10.1039/c4np00162a · Cited by 469
Kostova, I., Bhatia, S., Grigorov, P., Balkansky, S., S. Parmar, V., K. Prasad, A., & Saso, L. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711803414395 · Cited by 435
Anticancer activity of new coumarin substituted hydrazide–hydrazone derivatives
Nasr, T., Bondock, S., & Youns, M. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.02.026 · Cited by 334
Metadata
- Authors
- Riveiro, M., De Kimpe, N., Moglioni, A., Vazquez, R., Monczor, F., Shayo, C., & Davio, C.
- Venue
- Current Medicinal Chemistry
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2010-05-01
- Volume
- 17
- Issue
- 13
- Pages
- 1325-1338
- ISSN
- 0929-8673 (ISSN-L)
- OpenAlex
- W2128531001
- Cited by
- 448
- References
- 73
- FWCI
- 12.16
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.